Fundz

Resolution Therapeutics raised £63.5M in Series B financing led by Syncona Ltd to advance its lead candidate RTX001 for end-stage liver disease.

PRIVATEOct 03, 2024

Amount Raised

£63.5 Million

Round Type

Series B

EdinburghBiotechnologyresearch

Investors

Syncona Ltd

Description

Resolution Therapeutics, a clinical-stage biopharmaceutical company, raised £63.5M in Series B funding led by Syncona Ltd. The funds will be used to advance RTX001, a pro-regenerative macrophage cell therapy aimed at treating end-stage liver disease.

Quick answer

Resolution Therapeutics raised £63.5 Million in a Series B round, dated October 3, 2024. Investors: Syncona Ltd. Resolution Therapeutics is based in Edinburgh, Scotland, United Kingdom.

How much did Resolution Therapeutics raise?
Resolution Therapeutics raised £63.5 Million in a Series B round on October 3, 2024.
Who invested in Resolution Therapeutics?
Syncona Ltd is named as investors in this round.
What does Resolution Therapeutics do?
Resolution Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering regenerative macrophage therapy in inflammatory and fibrotic diseases.
Where is Resolution Therapeutics based and how big is it?
Resolution Therapeutics is based in Edinburgh, Scotland, United Kingdom. Fundz records about 72 employees.
Who are the decision-makers at Resolution Therapeutics?
Fundz holds 2 contacts at Resolution Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Resolution Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • FOXO Technologies raised $220K on November 15, 2024.
  • Geron raised $375M (Debt Financing) on November 7, 2024.
  • Aarvik Therapeutics raised $1.2M (Seed) on November 4, 2024.
  • Revalia Bio raised $12M on October 25, 2024.
  • Gameto raised $10M (Funding Round) on October 24, 2024.
  • FOXO Technologies raised $257K on October 17, 2024.

Who to call at Resolution Therapeutics, and when

A new round usually means Resolution Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Resolution Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Resolution Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Resolution Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Resolution Therapeutics

Location

Little France Drive

Edinburgh, Scotland, United Kingdom

About

Resolution Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering regenerative macrophage therapy in inflammatory and fibrotic diseases. The Company leverages its proprietary platform to develop macrophages with pro-regenerative properties for superior patient outcomes. Resolution's initial focus is on developing RTX001, its lead product with first-in-class potential supported by preclinical data demonstrating anti-fibrotic and anti-inflammatory advantages relative to non-engineered macrophages, to treat patients with end-stage liver disease. The Company is also advancing efforts to expand the potential of its platform into inflammatory and fibrotic indications beyond liver disease, including graft-vs-host disease (GVHD) and lung fibrosis. Resolution, a spinout from Professor Stuart Forbes's lab at the University of Edinburgh, is based in Edinburgh and London.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Resolution Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Resolution Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Resolution Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.